Oyster Point Pharma Inc
NASDAQ:OYST
Income Statement
Earnings Waterfall
Oyster Point Pharma Inc
Revenue
|
19.6m
USD
|
Cost of Revenue
|
-4.5m
USD
|
Gross Profit
|
15.1m
USD
|
Operating Expenses
|
-173.5m
USD
|
Operating Income
|
-158.5m
USD
|
Other Expenses
|
-18.2m
USD
|
Net Income
|
-176.6m
USD
|
Income Statement
Oyster Point Pharma Inc
Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
18
N/A
|
25
+37%
|
27
+11%
|
32
+17%
|
20
-39%
|
|
Gross Profit | |||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(3)
|
(5)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
N/A
|
7
+47%
|
11
+45%
|
15
+39%
|
|
Operating Income | |||||||||||||||
Operating Expenses |
(26)
|
(31)
|
(47)
|
(60)
|
(64)
|
(69)
|
(71)
|
(73)
|
(80)
|
(98)
|
(120)
|
(145)
|
(170)
|
(174)
|
|
Selling, General & Administrative |
(6)
|
(9)
|
(14)
|
(18)
|
(21)
|
(26)
|
(31)
|
(39)
|
(47)
|
(67)
|
(95)
|
(122)
|
(149)
|
(155)
|
|
Research & Development |
(20)
|
(22)
|
(34)
|
(43)
|
(43)
|
(43)
|
(40)
|
(34)
|
(32)
|
(30)
|
(24)
|
(23)
|
(21)
|
(19)
|
|
Operating Income |
(26)
N/A
|
(31)
-20%
|
(47)
-52%
|
(60)
-27%
|
(64)
-7%
|
(69)
-7%
|
(71)
-3%
|
(73)
-3%
|
(80)
-9%
|
(80)
-1%
|
(97)
-21%
|
(120)
-24%
|
(141)
-18%
|
(158)
-12%
|
|
Pre-Tax Income | |||||||||||||||
Interest Income Expense |
1
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
(1)
|
(4)
|
(7)
|
(10)
|
(12)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(3)
|
(6)
|
(6)
|
|
Pre-Tax Income |
(25)
N/A
|
(30)
-19%
|
(46)
-52%
|
(58)
-28%
|
(63)
-8%
|
(68)
-8%
|
(71)
-4%
|
(73)
-3%
|
(79)
-9%
|
(81)
-2%
|
(101)
-25%
|
(130)
-29%
|
(158)
-22%
|
(177)
-12%
|
|
Net Income | |||||||||||||||
Income from Continuing Operations |
(25)
|
(30)
|
(46)
|
(58)
|
(63)
|
(68)
|
(71)
|
(73)
|
(79)
|
(81)
|
(101)
|
(130)
|
(158)
|
(177)
|
|
Net Income (Common) |
(25)
N/A
|
(30)
-19%
|
(46)
-52%
|
(58)
-28%
|
(63)
-8%
|
(68)
-8%
|
(71)
-4%
|
(73)
-3%
|
(79)
-9%
|
(81)
-2%
|
(101)
-25%
|
(130)
-29%
|
(158)
-22%
|
(177)
-12%
|
|
EPS (Diluted) |
-1.22
N/A
|
-1.4
-15%
|
-2.14
-53%
|
-2.74
-28%
|
-2.7
+1%
|
-2.64
+2%
|
-2.72
-3%
|
-2.81
-3%
|
-3.06
-9%
|
-3.1
-1%
|
-3.84
-24%
|
-4.87
-27%
|
-5.89
-21%
|
-6.58
-12%
|